Orientations
Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) - update 15 March 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
This document has been updated: Version 30 July 2021.
Auteurs
Langues
- Anglais
Année de publication
2021
Type
Orientations
Catégories
- Vaccins et dispositifs d'administration
Maladies
- COVID-19
Pays
- Tchad
Organisations
- Organisation Mondiale de la Santé (OMS)
